ReviewCancer medicine2022

Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine-resistant differentiated thyroid cancer.

Elena Navarro-GonzalezPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.